Jorge Moll received his education in Rio de Janeiro at the Federal University. In 1994 he earned his medical degree. This was followed by the completion of his residency in neurology in 1998. In 2004 he earned his experimental pathophysiology degree. He is currently the President, senior researchers and board member of IDOR or the D’Or Institute of Research and Education. Dr. Jorge Moll was honored by Stanford University when he received the Visiting Scholar Award. In 2012 he was elected as a board member for the International Neuroethics Society. In 2008 the Brazilian Academy of Sciences elected him as an affiliate member. He attended the National Institutes of Health from 2004 until 2007 where he earned his Research Fellow accolade.
Dr. Jorge Moll believes people waste too much time acting on an idea. He feels this may deprive people of something that may benefit them. He stated an idea should be either discarded or implemented. He developed IDOR because he wanted to promote new innovations in healthcare. This passion turned into an idea that shaped his life. Meetings have become an important part of him remaining productive. This is when he discusses ideas and research. Dr. Jorge Moll has meetings with students, entrepreneurs, staff members, distinguished researchers, numerous organizations, scientists and business associates. He feels these meeting represent collaboration and free expression.
Dr. Jorge Moll believes the most difficult dilemma regarding ideas is choosing the ones most likely to achieve success. These ideas are discussed, dropped or an action plan is formed by him team. What intrigues him are artificial intelligence and cognitive systems. He finds watching the way machines and human brains work together with the purpose of improving healthcare exciting. He is also interested in regenerative medicine and gene therapy. Dr. Jorge Moll has become successful as an entrepreneur due to his openness, transparency and nimbleness. He believes innovative science has been stifled by publication and career pathways. He feels these challenges can be combated with new models so the higher risk projects can be accomplished easier. He feels new models are necessary to prevent people from continually performing the same actions.